View in EDS

Post Hematopoietic Cell Transplantation Maintenance Therapy With Low-Dose Azacitidine in a Pediatric Population With High-Risk Myeloid Malignancies.

Saved in:
Bibliographic Details
Title: Post Hematopoietic Cell Transplantation Maintenance Therapy With Low-Dose Azacitidine in a Pediatric Population With High-Risk Myeloid Malignancies.
Authors: Merkel EC; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington. Electronic address: emily.merkel@seattlechildrens.org., Gooley T; Fred Hutchinson Cancer Center, Seattle, Washington., Thakar MS; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Furlan SN; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Summers C; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Kirkey DC; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Hadland B; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Burroughs LM; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Carpenter PA; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Petrovic A; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Goshorn R; Sacred Heart Hospital, Spokane Washington., Irwin R; Mary Bridge Children's Hospital, Tacoma Washington., Bleakley M; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Cooper T; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Tarlock K; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington., Dahlberg A; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington.
Source: Transplantation and cellular therapy [Transplant Cell Ther] 2026 Apr; Vol. 32 (4), pp. 474.e1-474.e13. Date of Electronic Publication: 2025 Dec 05.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41354273
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Post Hematopoietic Cell Transplantation Maintenance Therapy With Low-Dose Azacitidine in a Pediatric Population With High-Risk Myeloid Malignancies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Merkel+EC%22">Merkel EC</searchLink>; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington. Electronic address: emily.merkel@seattlechildrens.org.<br /><searchLink fieldCode="AU" term="%22Gooley+T%22">Gooley T</searchLink>; Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Thakar+MS%22">Thakar MS</searchLink>; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Furlan+SN%22">Furlan SN</searchLink>; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Summers+C%22">Summers C</searchLink>; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Kirkey+DC%22">Kirkey DC</searchLink>; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Hadland+B%22">Hadland B</searchLink>; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Burroughs+LM%22">Burroughs LM</searchLink>; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Carpenter+PA%22">Carpenter PA</searchLink>; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Petrovic+A%22">Petrovic A</searchLink>; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Goshorn+R%22">Goshorn R</searchLink>; Sacred Heart Hospital, Spokane Washington.<br /><searchLink fieldCode="AU" term="%22Irwin+R%22">Irwin R</searchLink>; Mary Bridge Children's Hospital, Tacoma Washington.<br /><searchLink fieldCode="AU" term="%22Bleakley+M%22">Bleakley M</searchLink>; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Cooper+T%22">Cooper T</searchLink>; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Tarlock+K%22">Tarlock K</searchLink>; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Dahlberg+A%22">Dahlberg A</searchLink>; Fred Hutchinson Cancer Center, Seattle, Washington; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Department of Pediatrics,University of Washington, Seattle, Washington.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101774629%22">Transplantation and cellular therapy</searchLink> [Transplant Cell Ther] 2026 Apr; Vol. 32 (4), pp. 474.e1-474.e13. <i>Date of Electronic Publication: </i>2025 Dec 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101774629 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-6367 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226666367%22">26666367 </searchLink><i>NLM ISO Abbreviation: </i>Transplant Cell Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41354273
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jtct.2025.12.003
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 474.e1-474.e13
    Titles:
      – TitleFull: Post Hematopoietic Cell Transplantation Maintenance Therapy With Low-Dose Azacitidine in a Pediatric Population With High-Risk Myeloid Malignancies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Merkel EC
      – PersonEntity:
          Name:
            NameFull: Gooley T
      – PersonEntity:
          Name:
            NameFull: Thakar MS
      – PersonEntity:
          Name:
            NameFull: Furlan SN
      – PersonEntity:
          Name:
            NameFull: Summers C
      – PersonEntity:
          Name:
            NameFull: Kirkey DC
      – PersonEntity:
          Name:
            NameFull: Hadland B
      – PersonEntity:
          Name:
            NameFull: Burroughs LM
      – PersonEntity:
          Name:
            NameFull: Carpenter PA
      – PersonEntity:
          Name:
            NameFull: Petrovic A
      – PersonEntity:
          Name:
            NameFull: Goshorn R
      – PersonEntity:
          Name:
            NameFull: Irwin R
      – PersonEntity:
          Name:
            NameFull: Bleakley M
      – PersonEntity:
          Name:
            NameFull: Cooper T
      – PersonEntity:
          Name:
            NameFull: Tarlock K
      – PersonEntity:
          Name:
            NameFull: Dahlberg A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2666-6367
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Transplantation and cellular therapy
              Type: main
ResultId 1